EMD Millipore Opens Biomanufacturing Sciences Training Center in TokyoBy
EMD Millipore, the Life Science division of Merck KGaA, has opened a new Biomanufacturing Sciences Training Center (BSTC) facility in Tokyo. The facility is designed to help biopharmaceutical companies develop manufacturing processes and find solutions to processing challenges in collaboration with engineers from EMD Millipore.
Through the simulation of manufacturing process with products, the BSTC will allow customers to test equipment and devices, evaluate manufacturing processes, and conduct operator training. The training is intended to help biopharmaceutical companies expedite system implementation and enhance the efficiency of manufacturing process development while also providing quality assurance validations compliant with GMP standards and various regulations, thus lowering the risk when introducing new systems.
The new facility in Japan consists of a Pilot Scale Zone equipped with EMD Millipore's Mobius series of single-use components for demonstration testing for upstream and downstream processes. There is also a Process Development and Application Test Zone for various types of testing for process development and optimization, a Seminar & Training Zone, and a Gallery Zone with displays of EMD Millipore products.
EMD Millipore has BSTC facilities in nine major regions, including Japan, the US, Germany, France, Singapore, China, South Korea, India, and Brazil. EMD Millipore has invested EUR 1.3 million ($1.7 million) in the new project, which expands and relocates its existing BSTC operations in Yokohama, Kanagawa Prefecture into the larger facility in Tokyo.
Source: EMD Millipore